MIS plans to produce radiopharmaceuticals in U.K.
Molecular Imaging Services has signed an agreement to establish a commercial radiopharmaceutical production unit at Keele University Science Park in Staffordshire, U.K. The unit will produce PET radiopharmaceuticals. MIS was established in 2002 as a
Molecular Imaging Services has signed an agreement to establish a commercial radiopharmaceutical production unit at Keele University Science Park in Staffordshire, U.K. The unit will produce PET radiopharmaceuticals. MIS was established in 2002 as a joint venture between Phoenix-based Alliance Medical and Dublin-based M2i. Its primary goal is to establish a number of such production units to support the expanded use of PET in the U.K.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
